210 related articles for article (PubMed ID: 31400703)
1. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
[TBL] [Abstract][Full Text] [Related]
3. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
[TBL] [Abstract][Full Text] [Related]
4. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
5. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
[TBL] [Abstract][Full Text] [Related]
6. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
Shan W; Yang X; Ren Q; Wang Q
Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
[TBL] [Abstract][Full Text] [Related]
7. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
Tanaka Y; Higurashi N; Shirasu N; Yasunaga S; Moreira KM; Okano H; Hirose S
Stem Cell Res; 2018 Aug; 31():11-15. PubMed ID: 29981888
[TBL] [Abstract][Full Text] [Related]
12. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
[TBL] [Abstract][Full Text] [Related]
13. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
Shao Z; Cevallos RR; Hu K
Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
[TBL] [Abstract][Full Text] [Related]
15. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
16. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
Elife; 2016 Jul; 5():. PubMed ID: 27458797
[TBL] [Abstract][Full Text] [Related]
17. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
18. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
[TBL] [Abstract][Full Text] [Related]
19. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
[TBL] [Abstract][Full Text] [Related]
20. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Zhao H; He L; Li S; Huang H; Tang F; Han X; Lin Z; Tian C; Huang R; Zhou P; Huang J; Deng S; Li Z
Stem Cell Res; 2020 Jul; 46():101864. PubMed ID: 32544858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
